Citadel Advisors’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $544K | Buy |
|
|||||
|
2023
Q4 | $62K | Sell |
|
|||||
|
2023
Q3 | $176K | Sell |
|
|||||
|
2023
Q2 | $897K | Buy |
|
|||||
|
2023
Q1 | $316K | Buy |
|
|||||
|
2022
Q4 | $132K | Sell |
|
|||||
|
2022
Q3 | $3.85M | Buy |
|
|||||
|
2022
Q2 | $2.92M | Buy |
|
|||||
|
2022
Q1 | $2.41M | Sell |
|
|||||
|
2021
Q4 | $12.3M | Sell |
|
|||||
|
2021
Q3 | $15.9M | Buy |
|
|||||
|
2021
Q2 | $14M | Buy |
|
|||||
|
2021
Q1 | $11.1M | Buy |
|
|||||
|
2020
Q4 | $5.04M | Buy |
|
|||||
|
2020
Q3 | $658K | Buy |
|
|||||
|
2020
Q2 | $551K | Sell |
|
|||||
|
2020
Q1 | $2.53M | Buy |
|
|||||
|
2019
Q4 | $694K | Buy |
|
|||||
|
2019
Q3 | $325K | Buy |
|
|||||
|
2019
Q2 | $289K | Buy |
|